EDITORIAL SECTION

Articles

Designing Early-stage Formulation Strategies for Anti-microbial Peptides (Amps): A Major Prerequisite for Combating Anti-microbial Resistance

At present the world is witnessing an exponential increase in antimicrobial resistance AMR making it important for us to search alternatives to antibiotics in order to combat multidrug resistant MDR bacterial infections According to a study drugresistant infections were responsible for million deaths in globally The number of predicted deaths

The Synergy of Bioinformatics and Computational Biology in Genome Analysis

In the dynamic field of biological sciences the fusion of bioinformatics and computational biology has catalyzed a paradigm shift in genome analysis This synergistic collaboration harnesses cuttingedge computational tools statistical models

The Evolving Role of AI in Pharmaceutical Commercial Strategy

For most of the past decade the pharmaceutical industry told its artificial intelligence story from the laboratory bench Molecule generation protein structure prediction and trial simulation captured the headlines and the capital Yet the economics of this industry have never been settled in discovery alone

B2B Pharma Webinars: Driving Regulatory Insights for Decision-Makers

The regulatory intelligence in the modern dynamic pharmaceutical ecosystem cannot be just an office role any longer it is a strategic necessity With the changing world guidelines and digital transformation reallife evidences needed and crossborder compliance frameworks the decisionmakers have to keep pace with the incessant change in regulations

Artificial Intelligence and Deep/Machine Learning(AI & D/ML) or Artificial Neural Network (ANN): Implications for pharmaceutical product development processes

Producing pharmaceutical products without untoward effects but with desired qualities is not only the very basic requirement set by regulatory authorities but also indirectly decides the success of the pharma industry The pharmaceutical product development process is a combined and coordinated work from numerous divisions of the pharma industry which usually starts

How EU Pharmaceutical Reforms Could Change Drug Development and Market Access

For more than two decades the rules governing how medicines are developed authorised and protected in the European Union have rested on a directive from and a regulation from That foundation is about to be replaced The European Commission tabled its proposal for a new directive and regulation in April the European Parliament set its position in April

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG

PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys